# A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Uncomplicated Infections of the Skin and the Supportive Layers Beneath the Skin

> **NCT00257062** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 361 (actual)

## Conditions studied

- Skin Diseases, Infectious

## Interventions

- **DRUG:** Levofloxacin

## Key facts

- **NCT ID:** NCT00257062
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-01
- **Primary completion:** —
- **Final completion:** 1994-04
- **Target enrollment:** 361 (ACTUAL)
- **Last updated:** 2011-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00257062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00257062, "A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Uncomplicated Infections of the Skin and the Supportive Layers Beneath the Skin". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00257062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*